1-40302811-TGGAGGGAGGGAG-TGGAGGGAG
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP6_Very_StrongBS1
The NM_001852.4(COL9A2):c.1604-6_1604-3delCTCC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00355 in 524,462 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00036 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0046 ( 0 hom. )
Consequence
COL9A2
NM_001852.4 splice_region, intron
NM_001852.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.54
Genes affected
COL9A2 (HGNC:2218): (collagen type IX alpha 2 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 1-40302811-TGGAG-T is Benign according to our data. Variant chr1-40302811-TGGAG-T is described in ClinVar as [Likely_benign]. Clinvar id is 777748.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-40302811-TGGAG-T is described in Lovd as [Benign]. Variant chr1-40302811-TGGAG-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000357 (45/125902) while in subpopulation AMR AF= 0.00145 (18/12390). AF 95% confidence interval is 0.000938. There are 0 homozygotes in gnomad4. There are 24 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL9A2 | ENST00000372748.8 | c.1604-6_1604-3delCTCC | splice_region_variant, intron_variant | 1 | NM_001852.4 | ENSP00000361834.3 | ||||
COL9A2 | ENST00000482722.5 | n.1907-6_1907-3delCTCC | splice_region_variant, intron_variant | 1 | ||||||
COL9A2 | ENST00000427563.1 | n.360-6_360-3delCTCC | splice_region_variant, intron_variant | 3 | ||||||
COL9A2 | ENST00000466267.1 | n.569-6_569-3delCTCC | splice_region_variant, intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000366 AC: 46AN: 125804Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
46
AN:
125804
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00456 AC: 1816AN: 398560Hom.: 0 AF XY: 0.00424 AC XY: 913AN XY: 215180
GnomAD4 exome
AF:
AC:
1816
AN:
398560
Hom.:
AF XY:
AC XY:
913
AN XY:
215180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000357 AC: 45AN: 125902Hom.: 0 Cov.: 30 AF XY: 0.000401 AC XY: 24AN XY: 59824
GnomAD4 genome
AF:
AC:
45
AN:
125902
Hom.:
Cov.:
30
AF XY:
AC XY:
24
AN XY:
59824
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 03, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
COL9A2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 15, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at